ALMIRALL, S.A. «12345...» Page 2 out of 18 10/06/2024 08:04 ALMIRALL, S.A. On business and financial situation FDA approves Almirall’s Klisyri® (tirbanibulin) for the treatment of actinic keratosis on expanded area of face or scalp up to 100 cm2 Register number: 29062 05/06/2024 17:38 ALMIRALL, S.A. Other relevant information Information on dividend Register number: 29006 13/05/2024 07:03 ALMIRALL, S.A. On business and financial situation Almirall files First Quarter results presentation for 2024 Register number: 28622 12/05/2024 19:09 ALMIRALL, S.A. On business and financial situation Almirall announces that it will webcast a conference to introduce and explain the first quarter 2024 results Register number: 28620 12/05/2024 18:52 ALMIRALL, S.A. Other relevant information Information on Dividends: calendar Register number: 28619 12/05/2024 18:44 ALMIRALL, S.A. Other relevant information Information on Dividends Register number: 28618 12/05/2024 18:38 ALMIRALL, S.A. Announcement of general shareholders’ meeting Resolutions approved by the General Shareholders' Meeting 2024 Register number: 28617 12/05/2024 18:31 ALMIRALL, S.A. On corporate governance Resolutions approved by the Board of Directors Register number: 28616 10/04/2024 17:43 ALMIRALL, S.A. Liquidity and counterparty agreements Operaciones del contrato de liquidez durante el primer trimestre de 2024 Register number: 27967 08/04/2024 13:45 ALMIRALL, S.A. Announcement of general shareholders’ meeting Ordinary General Shareholders' Meeting of the Company Register number: 27890 Page 2 out of 18 «12345...»
